5 Articles
5 Articles
Trump’s drug pricing order puts Roche’s $50 billion U.S. investment plans at risk
President Donald Trump’s executive order on drug pricing threatens Roche’s planned $50 billion investment in the United States, the company said on Wednesday. Trump’s order, signed on Monday, directs drugmakers to lower prices of brand-name medicines to align with those in other wealthy nations. Analysts and legal experts say the policy would be difficult to implement. “Should the proposed EO (Executive Order) go into effect, Roche’s ability to …
Roche could reconsider the maxi investment plan in the USA – The Observatorial
The plans of President Donald Trump to lower drug prices could push Roche to reconsider his huge investments in the United States. This was stated by the Swiss pharmaceutical giant. Monday Trump announced a plan for Drastically reduce drug prices As a prescription in the United States, to align them at the lowest prices in […]
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage